These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 25134637)

  • 1. Analysis of leucocyte antibodies, cytokines, lysophospholipids and cell microparticles in blood components implicated in post-transfusion reactions with dyspnoea.
    Maślanka K; Uhrynowska M; Łopacz P; Wróbel A; Smoleńska-Sym G; Guz K; Lachert E; Ostas A; Brojer E
    Vox Sang; 2015 Jan; 108(1):27-36. PubMed ID: 25134637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of platelet-derived microparticles in stored apheresis platelet concentrates on polymorphonuclear leucocyte respiratory burst.
    Xie RF; Hu P; Li W; Ren YN; Yang J; Yang YM; Wang ZY; Fan HH
    Vox Sang; 2014 Apr; 106(3):234-41. PubMed ID: 24138005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytokines and clinical predictors in distinguishing pulmonary transfusion reactions.
    Roubinian NH; Looney MR; Kor DJ; Lowell CA; Gajic O; Hubmayr RD; Gropper MA; Koenigsberg M; Wilson GA; Matthay MA; Toy P; Murphy EL;
    Transfusion; 2015 Aug; 55(8):1838-46. PubMed ID: 25702590
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predicted effect of selectively testing female donors for HLA antibodies to mitigate transfusion-related acute lung injury risk from apheresis platelets.
    Eder AF; Dy BA; O'Neill EM
    Transfusion; 2016 Jun; 56(6 Pt 2):1608-15. PubMed ID: 26830063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differentiating pulmonary transfusion reactions using recipient and transfusion factors.
    Roubinian NH; Looney MR; Keating S; Kor DJ; Lowell CA; Gajic O; Hubmayr R; Gropper M; Koenigsberg M; Wilson GA; A Matthay M; Toy P; Murphy EL;
    Transfusion; 2017 Jul; 57(7):1684-1690. PubMed ID: 28470756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-leucocyte antibodies in platelet apheresis donors with and without prior immunizing events: implications for TRALI prevention.
    Sigle JP; Thierbach J; Infanti L; Muriset M; Hunziker G; Chassot K; Niederhauser C; Gowland P; Holbro A; Sunic K; Buser A; Fontana S
    Vox Sang; 2013 Oct; 105(3):244-52. PubMed ID: 23773018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An association between decreased cardiopulmonary complications (transfusion-related acute lung injury and transfusion-associated circulatory overload) and implementation of universal leukoreduction of blood transfusions.
    Blumberg N; Heal JM; Gettings KF; Phipps RP; Masel D; Refaai MA; Kirkley SA; Fialkow LB
    Transfusion; 2010 Dec; 50(12):2738-44. PubMed ID: 20561296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparing transfusion reaction rates for various plasma types: a systematic review and meta-analysis/regression.
    Saadah NH; van Hout FMA; Schipperus MR; le Cessie S; Middelburg RA; Wiersum-Osselton JC; van der Bom JG
    Transfusion; 2017 Sep; 57(9):2104-2114. PubMed ID: 28766723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transfusion-associated circulatory overload and transfusion-related acute lung injury.
    Semple JW; Rebetz J; Kapur R
    Blood; 2019 Apr; 133(17):1840-1853. PubMed ID: 30808638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathogenesis of non-antibody mediated transfusion-related acute lung injury from bench to bedside.
    Peters AL; van Hezel ME; Juffermans NP; Vlaar AP
    Blood Rev; 2015 Jan; 29(1):51-61. PubMed ID: 25277811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transfusion-related acute lung injury (TRALI): a serious adverse event of blood transfusion.
    Bux J
    Vox Sang; 2005 Jul; 89(1):1-10. PubMed ID: 15938734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of immunoreactive substances contained in apheresis platelet concentrate on postoperative respiratory function in surgical patients receiving platelet transfusion: a prospective cohort study.
    Kanai R; Iijima T; Hashimoto S; Nakazawa H; Ohnishi H; Yorozu T; Ohkawa R; Nojiri T; Shimizu M; Okazaki H
    Transfus Med; 2013 Oct; 23(5):344-50. PubMed ID: 23841680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lysophosphatidylcholines: bioactive lipids generated during storage of blood components.
    Maślanka K; Smoleńska-Sym G; Michur H; Wróbel A; Lachert E; Brojer E
    Arch Immunol Ther Exp (Warsz); 2012 Feb; 60(1):55-60. PubMed ID: 22167322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The association of biologically active lipids with the development of transfusion-related acute lung injury: a retrospective study.
    Silliman CC; Paterson AJ; Dickey WO; Stroneck DF; Popovsky MA; Caldwell SA; Ambruso DR
    Transfusion; 1997 Jul; 37(7):719-26. PubMed ID: 9225936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-polar lipids accumulate during storage of transfusion products and do not contribute to the onset of transfusion-related acute lung injury.
    Peters AL; Vervaart MA; van Bruggen R; de Korte D; Nieuwland R; Kulik W; Vlaar AP
    Vox Sang; 2017 Jan; 112(1):25-32. PubMed ID: 28097705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recommendations of the ISBT Working Party on Granulocyte Immunobiology for leucocyte antibody screening in the investigation and prevention of antibody-mediated transfusion-related acute lung injury.
    ; Bierling P; Bux J; Curtis B; Flesch B; Fung L; Lucas G; Macek M; Muniz-Diaz E; Porcelijn L; Reil A; Sachs U; Schuller R; Tsuno N; Uhrynowska M; Urbaniak S; Valentin N; Wikman A; Zupanska B
    Vox Sang; 2009 Apr; 96(3):266-9. PubMed ID: 19207164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proposed revised nomenclature for transfusion-related acute lung injury.
    Toy P; Kleinman SH; Looney MR
    Transfusion; 2017 Mar; 57(3):709-713. PubMed ID: 28019007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Epidemiology of Transfusion-related Acute Lung Injury Varies According to the Applied Definition of Lung Injury Onset Time.
    Vande Vusse LK; Caldwell E; Tran E; Hogl L; Dinwiddie S; López JA; Maier RV; Watkins TR
    Ann Am Thorac Soc; 2015 Sep; 12(9):1328-35. PubMed ID: 26102516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conversion to low transfusion-related acute lung injury (TRALI)-risk plasma significantly reduces TRALI.
    Arinsburg SA; Skerrett DL; Karp JK; Ness PM; Jhang J; Padmanabhan A; Gibble J; Schwartz J; King KE; Cushing MM
    Transfusion; 2012 May; 52(5):946-52. PubMed ID: 22060800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigating transfusion-related acute lung injury (TRALI).
    Fung YL; Goodison KA; Wong JK; Minchinton RM
    Intern Med J; 2003 Jul; 33(7):286-90. PubMed ID: 12823673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.